Back to Search
Start Over
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
- Source :
-
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1987 Feb; Vol. 5 (2), pp. 231-2. - Publication Year :
- 1987
-
Abstract
- With improvement and refinement of therapy, the majority of Hodgkin's disease patients are alive and free of disease at 5 years. As these patients continue to be observed, a variety of late complications have been reported. We describe herein three patients who developed retroperitoneal fibrosis following definitive therapy for Hodgkin's disease. The incidence approaches that seen with methysergide.
- Subjects :
- Adult
Combined Modality Therapy adverse effects
Humans
Male
Mechlorethamine adverse effects
Prednisone adverse effects
Procarbazine adverse effects
Time Factors
Vincristine adverse effects
Antineoplastic Combined Chemotherapy Protocols adverse effects
Hodgkin Disease therapy
Radiotherapy, High-Energy adverse effects
Retroperitoneal Fibrosis etiology
Ureteral Obstruction etiology
Subjects
Details
- Language :
- English
- ISSN :
- 0732-183X
- Volume :
- 5
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 3100728
- Full Text :
- https://doi.org/10.1200/JCO.1987.5.2.231